Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (521-530 of 842) with videos related to

Pageof 85
Sort By:
Journal of the American College of Cardiology|April 14, 2012
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flowJustin A Ezekowitz, Adrian F Hernandez, Christopher M O'Connor, et al.
Open Heart|November 30, 2018
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trialRoopinder K Sandhu, Justin A Ezekowitz, Ziad Hijazi, et al.
Thrombosis and Haemostasis|December 5, 2014
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
Plos One|December 5, 2014
Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndromeLarisa V Lysenko, Jeesun Kim, Cassandra Henry, et al.
Circulation|June 16, 2012
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trialJeff S Healey, John Eikelboom, James Douketis, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 1, 2023
Integration of longitudinal and circumferential strain predicts volumetric change across the cardiac cycle and differentiates patients along the heart failure continuumT Jake Samuel, Andrew P Oneglia, Daisha J Cipher, et al.
Circulation|July 31, 2015
Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and OutcomesWobo Bekwelem, Stuart J Connolly, Jonathan L Halperin, et al.
Thrombosis Research|February 27, 2016
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
Cardiovascular Diabetology|January 13, 2025
Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trialThomas H Marwick, Carolyn Lam, Yuxi Liu, et al.
Circulation|January 5, 2011
Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversionRangadham Nagarakanti, Michael D Ezekowitz, Jonas Oldgren, et al.
Pageof 85

Showing results (521-530 of 842) with videos related to

Sort By:
Pageof 85
Journal of the American College of Cardiology|April 14, 2012
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flowJustin A Ezekowitz, Adrian F Hernandez, Christopher M O'Connor, et al.
Open Heart|November 30, 2018
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trialRoopinder K Sandhu, Justin A Ezekowitz, Ziad Hijazi, et al.
Thrombosis and Haemostasis|December 5, 2014
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
Plos One|December 5, 2014
Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndromeLarisa V Lysenko, Jeesun Kim, Cassandra Henry, et al.
Circulation|June 16, 2012
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trialJeff S Healey, John Eikelboom, James Douketis, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 1, 2023
Integration of longitudinal and circumferential strain predicts volumetric change across the cardiac cycle and differentiates patients along the heart failure continuumT Jake Samuel, Andrew P Oneglia, Daisha J Cipher, et al.
Circulation|July 31, 2015
Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and OutcomesWobo Bekwelem, Stuart J Connolly, Jonathan L Halperin, et al.
Thrombosis Research|February 27, 2016
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
Cardiovascular Diabetology|January 13, 2025
Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trialThomas H Marwick, Carolyn Lam, Yuxi Liu, et al.
Circulation|January 5, 2011
Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversionRangadham Nagarakanti, Michael D Ezekowitz, Jonas Oldgren, et al.
Pageof 85